EXHIBIT 107
Calculation of Filing Fee Tables
Form
(Form Type)
Artelo Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Line Item Type |
| Security Type |
| Security Class Title |
| Fee Calculation Rule |
|
| Amount Registered |
| Proposed Maximum Offering Price Per Unit |
| Maximum Aggregate Offering Price |
|
| Fee Rate |
|
| Amount of Registration Fee |
| ||||
Newly Registered Securities | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
| $ | (1) |
|
|
|
| $ |
| ||||||||
|
|
|
|
|
|
|
|
| $ | (2) |
|
|
|
| $ |
| ||||||||
|
|
|
|
|
|
|
|
| $ | (3) |
|
|
|
| $ |
| ||||||||
|
|
|
|
|
|
|
|
| $ | (4) |
|
|
|
| $ |
| ||||||||
|
| Total Offering Amounts |
|
|
| $ |
|
|
| 0.00013810 |
|
| $ |
| ||||||||||
|
| Total Fees Previously Paid |
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||
|
| Total Fee Offsets |
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||
|
| Net Fee Due |
|
|
|
|
|
|
|
|
|
|
| $ |
| |||||||||
(1) | Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). Pursuant to Rule 416, there are also being registered such indeterminable additional securities as may be issued or resold to prevent dilution as a result of stock splits, stock dividends, recapitalizations, combinations, or similar transactions.
In accordance with Rule 457(g) under the Securities Act, no separate registration fee is required with respect to the pre-funded warrants registered hereby.
The proposed maximum aggregate offering price of the shares of Common Stock, proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants offered and sold in the offering, and as such the proposed maximum offering price of the shares of Common Stock and pre-funded warrants (including the shares of Common Stock issuable upon exercise of the pre-funded warrants), if any, is $12,000,000.
The registrant may issue pre-funded warrants to purchase shares of Common Stock in the offering. The purchase price of each pre-funded warrant will equal the price per share of Common Stock, minus $0.001, and the exercise price of each pre-funded warrant will be $0.001 per share of Common Stock. |
(2) | The proposed maximum aggregate offering price of the shares of Common Stock, proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants offered and sold in the offering, and as such the proposed maximum offering price of the shares of Common Stock and pre-funded warrants (including the shares of Common Stock issuable upon exercise of the pre-funded warrants), if any, is $12,000,000.
The registrant may issue pre-funded warrants to purchase shares of Common Stock in the offering. The purchase price of each pre-funded warrant will equal the price per share of Common Stock, minus $0.001, and the exercise price of each pre-funded warrant will be $0.001 per share of Common Stock. |
(3) | In accordance with Rule 457(g) under the Securities Act, no separate registration fee is required with respect to the placement agent warrants registered hereby. |
(4) | Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under the Securities Act. Pursuant to Rule 416, there are also being registered such indeterminable additional securities as may be issued or resold to prevent dilution as a result of stock splits, stock dividends, recapitalizations, combinations, or similar transactions.
The warrants registered hereby are exercisable for a number of shares of common stock that is equal to 8% of the aggregate number of shares of common stock and pre-funded warrants sold in this offering, at an assumed per share exercise price equal to 100% of the public offering price of the shares being offered to the investors in this offering. |